1Rogers, PJ, Appleton, KM, Kessler, D, Peters, TJ, Gunnell, D, Hayward, RC, Heatherley, SV, Christian, LM, McNaughton, SA & Ness, AR (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr 99, 421–431.
2Richardson, AJ (2008) n-3 Fatty acids and mood: the devil is in the detail. Br J Nutr 99, 221–223.
3Appleton, KM, Rogers, PJ & Ness, AR (2008) Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? Nutr Res Rev 21, .
4Hooper, L, Thompson, RL, Harrison, RA, et al. (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332, 752–755.
5Hibbeln, JR & Salem, N (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62, 1–9.
6Simopoulos, AP (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, , 560S–569S.
7Stoll, AL, Severus, WE, Freeman, MP, Rueter, S, Zboyan, HA, Diamond, E, Cress, KK & Marangell, LB (1999) Omega-3 fatty acids in bipolar disorder – a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56, 407–412.
8Scientific Advisory Committee on Nutrition & Committee on Toxicity (2004) Advice on Fish Consumption: Benefits and Risks. London: The Stationery Office.
9Marangell, LB, Martinez, JM, Zboyan, HA, Kertz, B, Seung Kim, HF & Puryear, LJ (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996–998.
10Silvers, KM, Woolley, CC, Hamilton, FC, Watts, PM & Watson, RA (2005) Randomized double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211–218.
11Grenyer, BFS, Crowe, T, Meyer, B, Owen, AJ, Grigonis-Deane, EM, Caputi, P & Howe, PRC (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropharmacol Biol Psychiatry 31, 1393–1396.
12Su, KP, Huang, SY, Chiu, CC & Shen, WW (2003) Omega-3 fatty acids in major depressive disorder – a preliminary double-blind placebo-controlled trial. Eur Neuropsychopharmacol 13, 267–271.
13Nemets, H, Nemets, B, Apter, A, Bracha, Z & Belmaker, RH (2006) Omega-3 treatment of children's depression: a controlled, double-blind pilot study. Am J Psychiatry 163, 1098–1100.
14Nemets, B, Stahl, Z & Belmaker, RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477–479.
15Peet, MB & Horrobin, DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913–919.
16Frangou, S, Lewis, M & McCrone, P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188, 46–50.
17Keck, PE Jr, Mintz, J, McElroy, SL, et al. (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60, 1020–1022.
18Hibbeln, JR, Nieminen, LRG, Blasbalg, TL, Riggs, JA & Lands, WEM (2006) Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr 83, Suppl. 6, 1483S–1493S.
19Hirashima, F, Parow, AM, Stoll, AL, Demopulos, CM, Damico, KE, Rohan, ML, Eskesen, JG, Zuo, CS, Cohen, BM & Renshaw, PF (2004) Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry 161, 1922–1924.
20Chalon, S, Delion-Vancassel, S, Blezung, C, Guilloteau, D, Leguisquet, AM, Besnard, JC & Durand, G (1998) Dietary fish oil affects monoaminergic neurotransmission and behaviour in rats. J Nutr 128, 2512–2519.
21Rogers, PJ (2001) A healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60, 135–143.
22Appleton, KM, Hayward, RC, Gunnell, D, Peters, TJ, Rogers, PJ, Kessler, D & Ness, AR (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr 84, 1308–1316.
23Zhang, J & Li, Y (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial – comments by Zhang and Li. Br J Nutr .
24Theodoratou, E, McNeill, G, Cetnarskyj, R, Farrington, SM, Tenesa, A, Barnetson, R, Porteous, M, Dunlop, M & Campbell, H (2007) Dietary fatty acids and colorectal cancer: a case–control study. Am J Epidemiol 166, 181–195.
25Kirsch, I, Deacon, BJ, Huedo-Medina, TB, Scoboria, A, Moore, TJ & Johnson, BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5, 260–267.
26Owen, AJ, Batterham, MJ, Probst, YC, Grenyer, BFS & Tapsell, LC (2005) Low vitamin E levels in major depression: diet or disease? Eur J Clin Nutr 59, 304–306.